Concepts (209)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Echocardiography | 18 | 2025 | 1131 | 1.750 |
Why?
|
| Heart Failure | 10 | 2024 | 2325 | 1.030 |
Why?
|
| Heart Ventricles | 7 | 2023 | 758 | 1.020 |
Why?
|
| Heart-Assist Devices | 6 | 2024 | 1018 | 0.830 |
Why?
|
| Calcinosis | 3 | 2012 | 178 | 0.800 |
Why?
|
| Volunteers | 1 | 2021 | 24 | 0.690 |
Why?
|
| Isolated Noncompaction of the Ventricular Myocardium | 2 | 2012 | 45 | 0.690 |
Why?
|
| Ecosystem | 1 | 2021 | 90 | 0.670 |
Why?
|
| Heart Diseases | 4 | 2022 | 499 | 0.630 |
Why?
|
| Emergency Medicine | 1 | 2022 | 172 | 0.610 |
Why?
|
| Heart Aneurysm | 2 | 2012 | 29 | 0.580 |
Why?
|
| Point-of-Care Systems | 1 | 2022 | 213 | 0.580 |
Why?
|
| Echocardiography, Transesophageal | 8 | 2013 | 247 | 0.580 |
Why?
|
| Mitral Valve | 5 | 2012 | 244 | 0.550 |
Why?
|
| Aortic Valve Insufficiency | 2 | 2013 | 147 | 0.520 |
Why?
|
| Cardiomyopathy, Hypertrophic | 2 | 2012 | 161 | 0.490 |
Why?
|
| Cardiology | 6 | 2024 | 514 | 0.480 |
Why?
|
| Pandemics | 1 | 2022 | 1112 | 0.430 |
Why?
|
| Takotsubo Cardiomyopathy | 1 | 2014 | 13 | 0.420 |
Why?
|
| Systole | 4 | 2023 | 195 | 0.410 |
Why?
|
| Radiology | 1 | 2015 | 119 | 0.410 |
Why?
|
| Incidental Findings | 2 | 2012 | 122 | 0.400 |
Why?
|
| Ventricular Function, Left | 5 | 2024 | 546 | 0.390 |
Why?
|
| Thrombosis | 3 | 2012 | 498 | 0.380 |
Why?
|
| Sinus of Valsalva | 1 | 2013 | 33 | 0.380 |
Why?
|
| Societies, Medical | 4 | 2025 | 791 | 0.370 |
Why?
|
| Ablation Techniques | 1 | 2012 | 30 | 0.350 |
Why?
|
| Pericardium | 1 | 2013 | 103 | 0.350 |
Why?
|
| Aortic Rupture | 1 | 2013 | 112 | 0.350 |
Why?
|
| American Heart Association | 4 | 2022 | 338 | 0.340 |
Why?
|
| Heart Valve Prosthesis Implantation | 3 | 2020 | 424 | 0.330 |
Why?
|
| Ethanol | 1 | 2012 | 167 | 0.320 |
Why?
|
| Humans | 48 | 2025 | 130085 | 0.310 |
Why?
|
| Echocardiography, Doppler, Color | 4 | 2013 | 114 | 0.300 |
Why?
|
| Quality Assurance, Health Care | 4 | 2013 | 205 | 0.300 |
Why?
|
| Myocardial Ischemia | 3 | 2014 | 308 | 0.300 |
Why?
|
| Diagnostic Imaging | 4 | 2014 | 304 | 0.300 |
Why?
|
| Methemoglobinemia | 1 | 2008 | 9 | 0.270 |
Why?
|
| Pericarditis, Constrictive | 1 | 2008 | 6 | 0.270 |
Why?
|
| Fluorocarbons | 2 | 2008 | 66 | 0.270 |
Why?
|
| Mitral Valve Stenosis | 1 | 2008 | 32 | 0.270 |
Why?
|
| Cardiac Tamponade | 1 | 2008 | 35 | 0.270 |
Why?
|
| Heart | 2 | 2022 | 659 | 0.260 |
Why?
|
| Palliative Care | 1 | 2012 | 445 | 0.260 |
Why?
|
| Tricuspid Valve | 1 | 2008 | 59 | 0.260 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2008 | 61 | 0.260 |
Why?
|
| Thoracic Injuries | 1 | 2008 | 82 | 0.260 |
Why?
|
| Pericardial Effusion | 1 | 2008 | 72 | 0.260 |
Why?
|
| Hematoma | 1 | 2008 | 85 | 0.250 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2008 | 79 | 0.250 |
Why?
|
| Cor Triatriatum | 1 | 2007 | 11 | 0.250 |
Why?
|
| Contrast Media | 2 | 2012 | 474 | 0.240 |
Why?
|
| Prosthesis Implantation | 2 | 2024 | 151 | 0.240 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2008 | 215 | 0.230 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2006 | 133 | 0.210 |
Why?
|
| Albumins | 1 | 2005 | 87 | 0.210 |
Why?
|
| Cardiomyopathies | 2 | 2016 | 521 | 0.210 |
Why?
|
| Vascular Resistance | 2 | 2024 | 182 | 0.210 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2013 | 1160 | 0.200 |
Why?
|
| Heart Septum | 1 | 2003 | 44 | 0.200 |
Why?
|
| Heart Neoplasms | 1 | 2005 | 108 | 0.200 |
Why?
|
| Multimodal Imaging | 1 | 2024 | 108 | 0.200 |
Why?
|
| Aortic Valve | 2 | 2020 | 454 | 0.190 |
Why?
|
| Ventricular Function, Right | 2 | 2022 | 128 | 0.190 |
Why?
|
| Heart Valve Prosthesis | 3 | 2004 | 302 | 0.190 |
Why?
|
| Chest Pain | 2 | 2022 | 121 | 0.190 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2012 | 365 | 0.180 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2024 | 178 | 0.180 |
Why?
|
| Advisory Committees | 2 | 2013 | 148 | 0.180 |
Why?
|
| Sarcoma | 1 | 2005 | 218 | 0.180 |
Why?
|
| Predictive Value of Tests | 5 | 2022 | 2290 | 0.180 |
Why?
|
| Ultrasonography | 3 | 2022 | 942 | 0.180 |
Why?
|
| United States | 13 | 2025 | 11896 | 0.180 |
Why?
|
| Male | 21 | 2024 | 64386 | 0.170 |
Why?
|
| Thrombolytic Therapy | 2 | 2004 | 191 | 0.170 |
Why?
|
| Cardiovascular Diseases | 5 | 2013 | 2107 | 0.170 |
Why?
|
| Pulmonary Artery | 1 | 2024 | 437 | 0.160 |
Why?
|
| Adult | 15 | 2025 | 31011 | 0.160 |
Why?
|
| Practice Guidelines as Topic | 3 | 2024 | 1282 | 0.160 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2002 | 172 | 0.160 |
Why?
|
| Echocardiography, Doppler | 3 | 2010 | 159 | 0.160 |
Why?
|
| Guideline Adherence | 2 | 2013 | 387 | 0.160 |
Why?
|
| Exercise Test | 1 | 2001 | 239 | 0.150 |
Why?
|
| Heart Valve Diseases | 1 | 2001 | 165 | 0.150 |
Why?
|
| Treatment Outcome | 7 | 2024 | 12821 | 0.140 |
Why?
|
| Female | 18 | 2024 | 70246 | 0.140 |
Why?
|
| Diastole | 1 | 1999 | 181 | 0.140 |
Why?
|
| Plasminogen Activators | 1 | 1998 | 17 | 0.140 |
Why?
|
| Echocardiography, Stress | 2 | 2008 | 19 | 0.140 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 1998 | 32 | 0.140 |
Why?
|
| Transcatheter Aortic Valve Replacement | 1 | 2020 | 227 | 0.130 |
Why?
|
| Nebivolol | 1 | 2016 | 4 | 0.130 |
Why?
|
| Vagus Nerve | 1 | 2017 | 50 | 0.130 |
Why?
|
| Adrenergic beta-1 Receptor Antagonists | 1 | 2016 | 12 | 0.130 |
Why?
|
| Prosthesis Failure | 1 | 1998 | 160 | 0.130 |
Why?
|
| Aortic Valve Stenosis | 1 | 2020 | 352 | 0.120 |
Why?
|
| Metoprolol | 1 | 2016 | 21 | 0.120 |
Why?
|
| Hemodynamics | 3 | 2013 | 810 | 0.120 |
Why?
|
| Middle Aged | 12 | 2024 | 28314 | 0.120 |
Why?
|
| Microspheres | 2 | 2008 | 66 | 0.120 |
Why?
|
| Defibrillators, Implantable | 2 | 2013 | 214 | 0.120 |
Why?
|
| Diagnostic Techniques, Cardiovascular | 2 | 2013 | 19 | 0.120 |
Why?
|
| Heart Conduction System | 1 | 2017 | 163 | 0.120 |
Why?
|
| Risk Assessment | 6 | 2024 | 3677 | 0.120 |
Why?
|
| Electrocardiography | 3 | 2014 | 972 | 0.120 |
Why?
|
| Botulinum Toxins | 1 | 2017 | 112 | 0.120 |
Why?
|
| Tachycardia, Ventricular | 1 | 2016 | 258 | 0.100 |
Why?
|
| Biomedical Technology | 1 | 2013 | 38 | 0.090 |
Why?
|
| Echocardiography, Three-Dimensional | 1 | 2013 | 64 | 0.090 |
Why?
|
| Cardiac Resynchronization Therapy | 1 | 2013 | 49 | 0.090 |
Why?
|
| Anticoagulants | 2 | 2012 | 598 | 0.090 |
Why?
|
| Follow-Up Studies | 4 | 2008 | 5167 | 0.090 |
Why?
|
| Coronary Angiography | 1 | 2014 | 449 | 0.090 |
Why?
|
| Heart Rate | 1 | 2014 | 576 | 0.080 |
Why?
|
| Cardiovascular Agents | 1 | 2012 | 87 | 0.080 |
Why?
|
| Laboratories, Hospital | 1 | 2011 | 24 | 0.080 |
Why?
|
| Diagnosis, Differential | 2 | 2008 | 1874 | 0.080 |
Why?
|
| Risk Factors | 4 | 2024 | 10960 | 0.080 |
Why?
|
| Aspirin | 1 | 2012 | 213 | 0.080 |
Why?
|
| Sex Factors | 1 | 2014 | 1343 | 0.080 |
Why?
|
| Aged | 8 | 2024 | 20821 | 0.080 |
Why?
|
| Retrospective Studies | 5 | 2024 | 17541 | 0.080 |
Why?
|
| Atrial Fibrillation | 1 | 2017 | 736 | 0.080 |
Why?
|
| Prosthesis Design | 3 | 2010 | 623 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2014 | 3741 | 0.070 |
Why?
|
| Drug Therapy, Combination | 1 | 2012 | 1165 | 0.070 |
Why?
|
| Pericardiectomy | 1 | 2008 | 9 | 0.070 |
Why?
|
| Cytochrome-B(5) Reductase | 1 | 2008 | 4 | 0.070 |
Why?
|
| Heart Transplantation | 2 | 2024 | 839 | 0.070 |
Why?
|
| Cyanosis | 1 | 2008 | 41 | 0.070 |
Why?
|
| Age Factors | 1 | 2014 | 2822 | 0.070 |
Why?
|
| Fatal Outcome | 1 | 2008 | 356 | 0.060 |
Why?
|
| Oximetry | 1 | 2008 | 176 | 0.060 |
Why?
|
| Venous Thrombosis | 1 | 2008 | 164 | 0.060 |
Why?
|
| Pulmonary Embolism | 1 | 2008 | 182 | 0.060 |
Why?
|
| Coronary Disease | 3 | 2008 | 627 | 0.050 |
Why?
|
| Injections, Intravenous | 1 | 2005 | 237 | 0.050 |
Why?
|
| Anesthetics, Dissociative | 1 | 2004 | 17 | 0.050 |
Why?
|
| Cardiac Imaging Techniques | 1 | 2024 | 26 | 0.050 |
Why?
|
| Radiography | 1 | 2006 | 740 | 0.050 |
Why?
|
| Death, Sudden | 1 | 2003 | 45 | 0.050 |
Why?
|
| Aged, 80 and over | 3 | 2012 | 6765 | 0.050 |
Why?
|
| Blood Flow Velocity | 1 | 2005 | 416 | 0.050 |
Why?
|
| Utilization Review | 2 | 2013 | 39 | 0.050 |
Why?
|
| Decision Making | 3 | 2014 | 712 | 0.050 |
Why?
|
| Polycystic Kidney Diseases | 1 | 2002 | 31 | 0.050 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2003 | 216 | 0.050 |
Why?
|
| Terminology as Topic | 1 | 2024 | 226 | 0.040 |
Why?
|
| Organ Size | 1 | 2022 | 408 | 0.040 |
Why?
|
| Health Services Research | 2 | 2013 | 178 | 0.040 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2007 | 774 | 0.040 |
Why?
|
| Ketamine | 1 | 2004 | 206 | 0.040 |
Why?
|
| Video Recording | 1 | 2002 | 193 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2003 | 1212 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2024 | 1227 | 0.040 |
Why?
|
| Dobutamine | 1 | 1999 | 48 | 0.040 |
Why?
|
| Patient Safety | 2 | 2014 | 443 | 0.040 |
Why?
|
| Internet | 1 | 2002 | 419 | 0.040 |
Why?
|
| Disease Progression | 1 | 2003 | 2191 | 0.030 |
Why?
|
| Patient Readmission | 1 | 2020 | 436 | 0.030 |
Why?
|
| Algorithms | 2 | 2014 | 1662 | 0.030 |
Why?
|
| Sheep | 1 | 2017 | 220 | 0.030 |
Why?
|
| Warfarin | 1 | 1998 | 123 | 0.030 |
Why?
|
| Sus scrofa | 1 | 2016 | 112 | 0.030 |
Why?
|
| Infusions, Intravenous | 1 | 1998 | 532 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2024 | 3026 | 0.030 |
Why?
|
| Ventricular Remodeling | 1 | 2016 | 154 | 0.030 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2016 | 134 | 0.030 |
Why?
|
| Ventricular Dysfunction | 1 | 1995 | 24 | 0.030 |
Why?
|
| Fibrosis | 1 | 2016 | 420 | 0.030 |
Why?
|
| Prognosis | 3 | 1999 | 4848 | 0.030 |
Why?
|
| Time Factors | 1 | 2024 | 6165 | 0.030 |
Why?
|
| Mutation | 1 | 2008 | 6067 | 0.030 |
Why?
|
| Stroke Volume | 1 | 2016 | 536 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2017 | 1604 | 0.020 |
Why?
|
| Hypotension | 1 | 1995 | 186 | 0.020 |
Why?
|
| Coronary Occlusion | 1 | 2013 | 34 | 0.020 |
Why?
|
| Radiation Dosage | 1 | 2013 | 131 | 0.020 |
Why?
|
| Vascular Calcification | 1 | 2013 | 69 | 0.020 |
Why?
|
| Cattle | 2 | 2004 | 500 | 0.020 |
Why?
|
| Mass Screening | 2 | 2008 | 817 | 0.020 |
Why?
|
| Myocytes, Cardiac | 1 | 2016 | 670 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2013 | 549 | 0.020 |
Why?
|
| Animals | 4 | 2017 | 33660 | 0.020 |
Why?
|
| Equipment Failure | 1 | 2010 | 122 | 0.020 |
Why?
|
| Adolescent | 1 | 2008 | 20800 | 0.020 |
Why?
|
| Myocardium | 1 | 2014 | 859 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2010 | 446 | 0.020 |
Why?
|
| Regional Health Planning | 1 | 2008 | 6 | 0.020 |
Why?
|
| Contraindications | 1 | 2008 | 75 | 0.020 |
Why?
|
| Comorbidity | 1 | 2013 | 1584 | 0.020 |
Why?
|
| Exercise | 1 | 2014 | 881 | 0.020 |
Why?
|
| Myocardial Revascularization | 1 | 2008 | 100 | 0.020 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2008 | 129 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2013 | 890 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2016 | 4639 | 0.010 |
Why?
|
| Preoperative Care | 1 | 2008 | 357 | 0.010 |
Why?
|
| Patient Selection | 1 | 2008 | 723 | 0.010 |
Why?
|
| Hematologic Tests | 1 | 2004 | 36 | 0.010 |
Why?
|
| Reference Standards | 1 | 2004 | 231 | 0.010 |
Why?
|
| Lung Diseases | 1 | 2007 | 397 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2010 | 2057 | 0.010 |
Why?
|
| Cardiac Catheterization | 1 | 2004 | 631 | 0.010 |
Why?
|
| Registries | 1 | 2004 | 1607 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2004 | 3114 | 0.010 |
Why?
|
| Intensive Care Units | 1 | 1995 | 525 | 0.010 |
Why?
|
| Critical Illness | 1 | 1995 | 623 | 0.010 |
Why?
|
| Survival Rate | 1 | 1995 | 2107 | 0.000 |
Why?
|
| Prospective Studies | 1 | 1995 | 6402 | 0.000 |
Why?
|